PMID- 19935649 OWN - NLM STAT- MEDLINE DCOM- 20091221 LR - 20211203 IS - 1476-4679 (Electronic) IS - 1465-7392 (Linking) VI - 11 IP - 12 DP - 2009 Dec TI - The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. PG - 1487-95 LID - 10.1038/ncb1998 [doi] AB - Invasion and metastasis of carcinomas is promoted by the activation of the embryonic 'epithelial to mesenchymal transition' (EMT) program, which triggers cellular mobility and subsequent dissemination of tumour cells. We recently showed that the EMT-activator ZEB1 (zinc finger E-box binding homeobox 1) is a crucial promoter of metastasis and demonstrated that ZEB1 inhibits expression of the microRNA-200 (miR-200) family, whose members are strong inducers of epithelial differentiation. Here, we report that ZEB1 not only promotes tumour cell dissemination, but is also necessary for the tumour-initiating capacity of pancreatic and colorectal cancer cells. We show that ZEB1 represses expression of stemness-inhibiting miR-203 and that candidate targets of miR-200 family members are also stem cell factors, such as Sox2 and Klf4. Moreover, miR-200c, miR-203 and miR-183 cooperate to suppress expression of stem cell factors in cancer cells and mouse embryonic stem (ES) cells, as demonstrated for the polycomb repressor Bmi1. We propose that ZEB1 links EMT-activation and stemness-maintenance by suppressing stemness-inhibiting microRNAs (miRNAs) and thereby is a promoter of mobile, migrating cancer stem cells. Thus, targeting the ZEB1-miR-200 feedback loop might form the basis of a promising treatment for fatal tumours, such as pancreatic cancer. FAU - Wellner, Ulrich AU - Wellner U AD - Department of Visceral Surgery, University of Freiburg, 79106 Freiburg, Germany. FAU - Schubert, Jorg AU - Schubert J FAU - Burk, Ulrike C AU - Burk UC FAU - Schmalhofer, Otto AU - Schmalhofer O FAU - Zhu, Feng AU - Zhu F FAU - Sonntag, Annika AU - Sonntag A FAU - Waldvogel, Bettina AU - Waldvogel B FAU - Vannier, Corinne AU - Vannier C FAU - Darling, Douglas AU - Darling D FAU - zur Hausen, Axel AU - zur Hausen A FAU - Brunton, Valerie G AU - Brunton VG FAU - Morton, Jennifer AU - Morton J FAU - Sansom, Owen AU - Sansom O FAU - Schuler, Julia AU - Schuler J FAU - Stemmler, Marc P AU - Stemmler MP FAU - Herzberger, Christoph AU - Herzberger C FAU - Hopt, Ulrich AU - Hopt U FAU - Keck, Tobias AU - Keck T FAU - Brabletz, Simone AU - Brabletz S FAU - Brabletz, Thomas AU - Brabletz T LA - eng GR - C157/A9148/Cancer Research UK/United Kingdom PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20091122 PL - England TA - Nat Cell Biol JT - Nature cell biology JID - 100890575 RN - 0 (Homeodomain Proteins) RN - 0 (KLF4 protein, human) RN - 0 (Klf4 protein, mouse) RN - 0 (Kruppel-Like Factor 4) RN - 0 (Kruppel-Like Transcription Factors) RN - 0 (MicroRNAs) RN - 0 (Transcription Factors) RN - 0 (ZEB1 protein, human) RN - 0 (ZEB1 protein, mouse) RN - 0 (Zinc Finger E-box-Binding Homeobox 1) SB - IM MH - Animals MH - Base Sequence MH - *Cell Differentiation MH - Cell Line, Tumor MH - Epithelial Cells/cytology/metabolism MH - Gene Expression Profiling MH - Gene Expression Regulation, Neoplastic MH - Homeodomain Proteins/genetics/*metabolism MH - Humans MH - Kruppel-Like Factor 4 MH - Kruppel-Like Transcription Factors/genetics/*metabolism MH - Male MH - Mesenchymal Stem Cells/cytology/metabolism MH - Mice MH - Mice, Nude MH - MicroRNAs/*genetics MH - Neoplasms/genetics/*metabolism/pathology MH - Sequence Alignment MH - Transcription Factors/*metabolism MH - Xenograft Model Antitumor Assays MH - Zinc Finger E-box-Binding Homeobox 1 EDAT- 2009/11/26 06:00 MHDA- 2009/12/22 06:00 CRDT- 2009/11/26 06:00 PHST- 2009/05/06 00:00 [received] PHST- 2009/10/22 00:00 [accepted] PHST- 2009/11/26 06:00 [entrez] PHST- 2009/11/26 06:00 [pubmed] PHST- 2009/12/22 06:00 [medline] AID - ncb1998 [pii] AID - 10.1038/ncb1998 [doi] PST - ppublish SO - Nat Cell Biol. 2009 Dec;11(12):1487-95. doi: 10.1038/ncb1998. Epub 2009 Nov 22.